Onderneming Therapeutic Solutions International, Inc. Other OTC
Aandelen
TSOI
US8833781011
Medische apparatuur, benodigdheden & distributie
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Immune Modulation
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -52,12% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -52,12% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Timothy Dixon
CEO | Chief Executive Officer | 66 | 31-03-11 |
James Veltmeyer
CTO | Chief Tech/Sci/R&D Officer | 59 | 18-06-18 |
Feng Lin
CTO | Chief Tech/Sci/R&D Officer | 54 | 03-09-19 |
Famela Ramos
PRN | Corporate Officer/Principal | 48 | - |
Serena Robella
SAM | Sales & Marketing | - | 12-10-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Thomas Ichim
BRD | Director/Board Member | 49 | 22-01-16 |
Timothy Dixon
CEO | Chief Executive Officer | 66 | 31-03-11 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 4 230 116 869 | 3 318 983 291 ( 78,46 %) | 0 | 78,46 % |
Bedrijfsgegevens
Therapeutic Solutions International, Inc.
701 Wild Rose Lane
83525, Elk
+
http://www.therapeuticsolutionsint.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,57% | 126 mld. | |
-4,96% | 11,27 mld. | |
+3,22% | 9,12 mld. | |
+38,90% | 5,61 mld. | |
-21,83% | 4,75 mld. | |
+8,74% | 3,45 mld. | |
-6,82% | 2,89 mld. | |
-13,32% | 2,07 mld. | |
-6,99% | 2,05 mld. |